Overview

Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease

Status:
Completed

Trial end date:
2017-10-19

Target enrollment:

Participant gender:

Summary

Er:YAG ablative fractional laser-assisted methyl aminolevulinate photodynamic therapy (AFL-PDT) has shown significantly higher efficacy and a lower recurrence rate at 12 months than methyl aminolevulinate photodynamic therapy (MAL-PDT) for treatment of Bowen's disease (BD). However, long-term follow up data are not available.

Phase:

Phase 1

Details

Lead Sponsor:

Dong-A University

Treatments:

Aminolevulinic Acid
EMLA
Lidocaine
Lidocaine, Prilocaine Drug Combination
Methyl 5-aminolevulinate
Prilocaine